C17orf67

gene
On this page

Summary

C17orf67 (chromosome 17 open reading frame 67, HGNC:27900) is a protein-coding gene on chromosome 17q22, encoding Uncharacterized protein C17orf67 (Q0P5P2).

Predicted to be located in extracellular region.

Source: NCBI Gene 339210 — RefSeq curated summary.

At a glance

  • GWAS associations: 13
  • Clinical variants (ClinVar): 7 total
  • MANE Select transcript: NM_001085430

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:27900
Approved symbolC17orf67
Namechromosome 17 open reading frame 67
Location17q22
Locus typegene with protein product
StatusApproved
Ensembl geneENSG00000214226
Ensembl biotypeprotein_coding
Entrez339210

Gene structure

Transcript identifiers

Ensembl transcripts: 22 — 20 protein_coding, 1 protein_coding_CDS_not_defined, 1 retained_intron

ENST00000397861, ENST00000487705, ENST00000570754, ENST00000870326, ENST00000870327, ENST00000870328, ENST00000870329, ENST00000870330, ENST00000870331, ENST00000870332, ENST00000870333, ENST00000870334, ENST00000870335, ENST00000870336, ENST00000870337, ENST00000870338, ENST00000870339, ENST00000870340, ENST00000870341, ENST00000939699, ENST00000971316, ENST00000971317

RefSeq mRNA: 1 — MANE Select: NM_001085430 NM_001085430

CCDS: CCDS42364

Canonical transcript exons

ENST00000397861 — 8 exons

ExonStartEnd
ENSE000015305025683361856833920
ENSE000015305045679504456795180
ENSE000015305055681486956814969
ENSE000015305075681575656816010
ENSE000015305095682473956824853
ENSE000015305105682508156825321
ENSE000015305125683289856833342
ENSE000019290775679191356792352

Expression profiles

Bgee: expression breadth ubiquitous, 169 present calls, max score 85.31.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 4.3744 / max 49.1111, expressed in 1616 samples.

FANTOM5 promoters (8 alternative TSS)

Promoter IDTPM avgSamples expressed
1671092.83961345
1671101.4023862
1671080.084428
1671050.01325
1671040.01203
1671060.01025
1670980.00925
1671070.00352

Top tissues by expression

241 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047385.31gold quality
kidney epitheliumUBERON:000481984.77gold quality
upper arm skinUBERON:000426383.06gold quality
pancreatic ductal cellCL:000207982.88silver quality
gingival epitheliumUBERON:000194982.73gold quality
thymusUBERON:000237080.54gold quality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099179.73gold quality
mucosa of paranasal sinusUBERON:000503079.00gold quality
gingivaUBERON:000182878.40gold quality
epithelial cell of pancreasCL:000008376.83gold quality
cardiac muscle of right atriumUBERON:000337976.45gold quality
superficial temporal arteryUBERON:000161476.19gold quality
left ventricle myocardiumUBERON:000656676.13gold quality
cardia of stomachUBERON:000116275.43silver quality
vena cavaUBERON:000408775.28gold quality
subthalamic nucleusUBERON:000190675.26gold quality
cerebellar vermisUBERON:000472075.24gold quality
ponsUBERON:000098875.08gold quality
tibialis anteriorUBERON:000138574.78silver quality
lateral globus pallidusUBERON:000247674.63gold quality
dorsal plus ventral thalamusUBERON:000189774.43gold quality
pharyngeal mucosaUBERON:000035574.40gold quality
right lobe of liverUBERON:000111474.34gold quality
tracheaUBERON:000312674.28gold quality
body of tongueUBERON:001187674.26gold quality
pericardiumUBERON:000240774.24gold quality
tongueUBERON:000172374.13gold quality
nippleUBERON:000203074.07gold quality
lateral nuclear group of thalamusUBERON:000273674.04gold quality
lower esophagus mucosaUBERON:003583473.99gold quality

Single-cell (SCXA)

Detected in 2 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-MTAB-6701yes14.92
E-ANND-3no2.75

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

26 targeting C17orf67, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-5011-5P100.0083.465820
HSA-MIR-4776-3P100.0068.731340
HSA-MIR-366299.9973.825684
HSA-MIR-314899.9775.066478
HSA-MIR-426799.9666.532368
HSA-MIR-544A99.8468.661965
HSA-MIR-3156-3P99.7666.72939
HSA-MIR-5004-5P99.6866.631294
HSA-MIR-65799.4866.02848
HSA-MIR-312599.1468.492269
HSA-MIR-391698.9968.042155
HSA-MIR-6859-5P98.9968.072049
HSA-MIR-5197-3P98.7167.051905
HSA-MIR-4436B-3P98.2565.261494
HSA-MIR-6735-5P98.2465.361488
HSA-MIR-7843-5P98.1265.261421
HSA-MIR-4632-5P97.8265.381470
HSA-MIR-6879-5P97.7765.521521
HSA-MIR-4714-5P97.0467.76955
HSA-MIR-290996.3667.30562
HSA-MIR-1245A96.3366.25498
HSA-MIR-807996.3366.11484
HSA-MIR-5586-5P96.2968.02685
HSA-MIR-4761-3P96.2766.26524
HSA-MIR-431-5P96.1666.50652
HSA-MIR-473789.9465.0382

Cross-species orthologs

3 orthologs

OrganismSymbolGene ID
danio_reriosi:dkey-31g6.6ENSDARG00000101393
mus_musculusGm525ENSMUSG00000072553
rattus_norvegicusC10h17orf67ENSRNOG00000064206

Protein

Protein identifiers

Uncharacterized protein C17orf67Q0P5P2 (reviewed: Q0P5P2)

All UniProt accessions (1): Q0P5P2

UniProt curated annotations — full annotation on UniProt →

Subcellular location. Secreted.

RefSeq proteins (1): NP_001078899* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR027870DUF4543Family

Pfam: PF15076

UniProt features (3 total): signal peptide 1, chain 1, region of interest 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q0P5P2-F176.760.15

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 36 (showing top): NIKOLSKY_BREAST_CANCER_17Q21_Q25_AMPLICON, chr17q22, LI_INDUCED_T_TO_NATURAL_KILLER_DN, DLX2_TARGET_GENES, NAB2_TARGET_GENES, ZNF146_TARGET_GENES, ZNF711_TARGET_GENES, ZSCAN30_TARGET_GENES, MIR3125, MIR3916, MIR6859_5P, MIR544A, MIR4436B_3P, MIR6879_5P, MIR6735_5P

GO Biological Process (0):

GO Molecular Function (1): protein binding (GO:0005515)

GO Cellular Component (1): extracellular region (GO:0005576)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
binding1
cellular anatomical structure1

Protein interactions and networks

STRING

294 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
C17orf67BSPH1Q075Z2572
C17orf67ANKFN1Q8N957560
C17orf67DGKEP52429538
C17orf67RUFY1Q96T51490
C17orf67RFLNAQ6ZTI6462
C17orf67DOT1LQ8TEK3461
C17orf67ILRUNQ9H6K1446
C17orf67ANKARQ7Z5J8446
C17orf67FAM180AQ6UWF9437
C17orf67SYNGR2O43760435
C17orf67BNC2Q6ZN30430
C17orf67POC5Q8NA72423
C17orf67SCPEP1Q9HB40414
C17orf67PINLYPA6NC86394
C17orf67HSPG2P98160389

IntAct

10 interactions, top by confidence:

ABTypeScore
C17orf67CADPSpsi-mi:“MI:0915”(physical association)0.560
GOPCC17orf67psi-mi:“MI:0915”(physical association)0.560
C17orf67GOPCpsi-mi:“MI:0915”(physical association)0.560
C17orf67OPTNpsi-mi:“MI:0915”(physical association)0.560

BioGRID (2): C17orf67 (Two-hybrid), C17orf67 (Two-hybrid)

ESM2 similar proteins: A0A0K8RAI0, A0A0K8RCU3, A0A0K8RDJ1, A0A141SFN4, A0A158RFT4, A0A1D0BN92, B4G532, B4R1P9, C0HKG1, D3JWK7, E2J6T4, E9Q7F5, F5HB98, F5HHQ0, O08546, O36359, P01587, P04671, P08864, P0CD95, P0CE75, P0CE76, P0DPY3, P0DPY9, P0DQE5, P0DQV0, P11450, P25140, P28907, P28981, P33496, P34468, P54356, P68326, P68329, P86899, P89679, Q00997, Q0P5P2, Q17RF5

Diamond homologs: P0CD95, Q0P5P2, Q3V3I5

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

7 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance1
Likely benign0
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

1630 predictions. Top by Δscore:

VariantEffectΔscore
17:56797779:T:TAdonor_gain0.9900
17:56827323:CTG:Cdonor_gain0.9900
17:56834257:CGAG:Cdonor_loss0.9900
17:56834259:AG:Adonor_loss0.9900
17:56834260:GGTA:Gdonor_loss0.9900
17:56834312:GGGC:Gdonor_gain0.9900
17:56835203:T:Gdonor_gain0.9900
17:56835214:TTTGC:Tdonor_gain0.9900
17:56792353:C:CCacceptor_gain0.9800
17:56799903:T:Cacceptor_gain0.9800
17:56815037:C:CTacceptor_gain0.9800
17:56834773:GTTA:Gacceptor_loss0.9800
17:56834775:TA:Tacceptor_loss0.9800
17:56834776:A:ATacceptor_loss0.9800
17:56835255:TACAG:Tdonor_loss0.9800
17:56835256:ACAG:Adonor_loss0.9800
17:56835257:CAGG:Cdonor_loss0.9800
17:56835258:AGGTA:Adonor_loss0.9800
17:56835259:GG:Gdonor_loss0.9800
17:56835260:G:GAdonor_loss0.9800
17:56835261:T:Cdonor_loss0.9800
17:56834771:T:TAacceptor_gain0.9700
17:56834772:G:Aacceptor_gain0.9700
17:56835123:GAGAT:Gdonor_gain0.9700
17:56795181:C:CCacceptor_gain0.9600
17:56799903:T:TCacceptor_gain0.9600
17:56815038:A:Tacceptor_gain0.9600
17:56816524:TTACA:Tacceptor_gain0.9600
17:56827322:A:ACdonor_gain0.9600
17:56827323:C:CCdonor_gain0.9600

AlphaMissense

581 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
17:56814887:G:CF46L0.971
17:56814887:G:TF46L0.971
17:56814889:A:GF46L0.971
17:56795118:C:AW73C0.949
17:56795118:C:GW73C0.949
17:56795112:G:CN75K0.948
17:56795112:G:TN75K0.948
17:56795104:C:GC78S0.945
17:56795105:A:TC78S0.945
17:56814896:T:AK43N0.942
17:56814896:T:GK43N0.942
17:56795092:C:GC82S0.941
17:56795093:A:TC82S0.941
17:56795164:A:GL58P0.941
17:56814940:C:GA29P0.941
17:56795104:C:TC78Y0.940
17:56814923:T:AR34S0.938
17:56814923:T:GR34S0.938
17:56795103:G:CC78W0.935
17:56795092:C:TC82Y0.930
17:56814930:A:GL32P0.926
17:56795091:A:CC82W0.925
17:56795105:A:GC78R0.921
17:56795116:A:GL74P0.919
17:56795093:A:GC82R0.910
17:56795104:C:AC78F0.910
17:56795152:T:AE62V0.909
17:56795120:A:GW73R0.907
17:56795120:A:TW73R0.907
17:56814924:C:GR34T0.906

dbSNP variants (sampled 300 via entrez): RS1000030102 (17:56792026 A>G), RS1000037684 (17:56807638 T>C), RS1000051377 (17:56807042 G>A), RS1000073733 (17:56833662 TC>T,TCC), RS1000125769 (17:56818221 T>C), RS1000203214 (17:56832136 C>T), RS1000257081 (17:56828582 T>C), RS1000286577 (17:56828291 G>T), RS1000349824 (17:56797832 G>A), RS1000365471 (17:56820459 C>T), RS1000393002 (17:56820634 C>T), RS1000501656 (17:56809408 G>A,T), RS1000510378 (17:56833497 G>A), RS1000598161 (17:56816248 A>G), RS1000744945 (17:56826287 T>C)

Disease associations

OMIM: gene `` | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

13 associations (top):

StudyTraitp-value
GCST002647_151Height1.000000e-23
GCST002702_2Height6.000000e-06
GCST004132_96Crohn’s disease4.000000e-06
GCST004166_28Nonsyndromic cleft lip with cleft palate9.000000e-09
GCST005537_34Chronic inflammatory diseases (ankylosing spondylitis, Crohn’s disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)2.000000e-08
GCST006291_37Spherical equivalent or myopia (age of diagnosis)2.000000e-12
GCST008058_256Estimated glomerular filtration rate7.000000e-13
GCST008178_13Early spontaneous preterm birth8.000000e-06
GCST008839_301Height4.000000e-17
GCST010988_64Adult body size4.000000e-08
GCST012226_800Waist circumference adjusted for body mass index1.000000e-10
GCST012226_801Waist circumference adjusted for body mass index4.000000e-08
GCST012227_343Hip circumference adjusted for BMI5.000000e-11

EFO canonical traits (5, from GWAS)

EFO IDTrait name
EFO:0003959cleft lip
EFO:0004847age at onset
EFO:0006917spontaneous preterm birth
EFO:0007789BMI-adjusted waist circumference
EFO:0008039BMI-adjusted hip circumference

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

18 total (human), top 18 by PubMed support.

ChemicalActions (top 5)PubMed papers
Air Pollutantsaffects expression, increases abundance, decreases expression2
Tobacco Smoke Pollutionincreases expression2
butyraldehydedecreases expression1
PCI 5002affects cotreatment, increases expression1
Sunitinibincreases expression1
Acetaminophenincreases expression1
Arsenicaffects methylation1
Benzo(a)pyreneincreases methylation1
Drugs, Chinese Herbalincreases expression1
Methotrexatedecreases expression1
Naphthoquinonesincreases expression1
Ozoneaffects expression, increases abundance1
Silicon Dioxidedecreases expression1
Zincincreases expression, affects cotreatment1
Cadmium Chloridedecreases expression1
Acrylamideincreases expression1
Permethrindecreases expression1
Particulate Matterdecreases expression, increases abundance1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.